et al., Annals of the Rheumatic Diseases, doi:10.1136/annrheumdis-2020-217690 (Letter)
Analysis of 80 SLE patients diagnosed with COVID-19, showing the frequency of hospitalisation did not differ between individuals using an antimalarial versus non-users (55% (16/29) vs 57% (29/51), p
=ns. Authors suggest that the dosage used may be too low to reach therapeutic levels.
Konig et al., 5/7/2020, retrospective, database analysis, multiple countries, multiple regions, preprint, 11 authors.
risk of hospitalization, 3.0% lower, RR 0.97, p = 0.88, treatment 16 of 29 (55.2%), control 29 of 51 (56.9%).